Zhongguo shuxue zazhi (Apr 2023)

Establishment of human monoclonal hybridoma cell lines specific for PP1Pk antigens from peripheral B lymphocytes of a p[Tj(a-)] donor

  • Zhonghui GUO,
  • Ziyan ZHU,
  • Dong XIANG,
  • Fengyong ZHAO,
  • Ying YANG

DOI
https://doi.org/10.13303/j.cjbt.issn.1004-549x.2023.04.004
Journal volume & issue
Vol. 36, no. 4
pp. 294 – 298

Abstract

Read online

Objective To establish lymphoblastoid cell line (LCL) and human monoclonal antibody cell lines against PP1Pk antigens from a donor with rare p[Tj(a-)] phenotype. Methods Peripheral blood mononuclear cells (PBMCs)of an O type p[Tj(a-)] donor were prepared and transformed with Epstein-Barr virus (EBV) in vitro. Normal AB and O type red blood cells treated with bromelain as well as p[Tj (a-)] were used to screen the culture supernatant. The transformed LCL secreting antibodies to PP1Pk antigens was picked up and then hybridized with the SHM-D33 cell line using electric fusion technique. The hybridomas were performed by HOTD selective culture, antibody screening and limited dilution subcloning. Results We established a lymphoblastoid cell line 5E1-E5 and several monoclonal hybridoms cell lines secreting anti-PP1Pk immunoglobulin M from EBV transformed B lymphocytes of a p[Tj(a-)] type donor with anti-PP1Pk successfully. Conclusion Our work made it possible for screening rare p[Tj(a-)] blood type in donor population in China using human monoclonal anti-PP1Pk antibodies, which was important for the establishment of rare blood group banks in China.

Keywords